Cargando…
Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study
BACKGROUND: In elderly patients (≥65 years of age) with epilepsy who take medications for comorbid conditions, some antiepileptic drugs (AEDs) may alter the metabolism of other treatments and increase the risk of adverse consequences and healthcare utilisation. This analysis compares healthcare cost...
Autores principales: | Borghs, Simon, Byram, Laura, Chan, Jane, Dedeken, Peter, Logan, John, Kiri, Victor, Noack-Rink, Matthias, Patsalos, Philip N., Thieffry, Solène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947959/ https://www.ncbi.nlm.nih.gov/pubmed/31914953 http://dx.doi.org/10.1186/s12883-019-1587-9 |
Ejemplares similares
-
Health care cost associated with the use of enzyme-inducing and non-enzyme–active antiepileptic drugs in the UK: a long-term retrospective matched cohort study
por: Borghs, Simon, et al.
Publicado: (2017) -
Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta‐analyses and real‐world evidence on antiepileptic drugs
por: Thieffry, Solène, et al.
Publicado: (2020) -
Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records
por: Powell, Graham, et al.
Publicado: (2019) -
Lacosamide and sodium channel‐blocking antiepileptic drug cross‐titration against levetiracetam background therapy
por: Baulac, M., et al.
Publicado: (2016) -
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
por: Saruwatari, Junji, et al.
Publicado: (2010)